Continuation of d10: product id {{d-evolutfx-34}}; product lot/serial number {{unknown}}; product type: {{0195-heart valves}}; implant date {{n/a}}; explant date {{n/a}} product id {{l-evolutfx-34}}; product lot/serial number {{unknown}}; product type: {{0195-heart valves}}; implant date {{n/a}}; explant date {{n/a}}.Medtronic has requested additional information pertaining to this reportable event.If additional reportable information is received, a supplemental report will be submitted. medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the valve dislodged deep at implan tation.11 days following implant of the valve, the valve failed due to paravalvular leak (pvl) and the patient was experiencing heart failure.Angiography was performed to determine the depth of the valve and to see the pvl.The valve frame was 11.2-16 millimeter's (mm) deep to the native annulus.Subsequently, a non-medtronic transcatheter valve was implanted valve-in-valve.It was noted that the depth of initial implant caused/contributed to the event.No additional adverse patient effects were reported.
|